⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

Official Title: A Phase II, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of CYH33, a Selective PI3Kα Inhibitor in Patients With Recurrent/Persistent Ovary, Fallopian Tube or Primary Peritoneal Clear Cell Carcinoma

Study ID: NCT05043922

Interventions

CYH33

Study Description

Brief Summary: The purpose of this study is to determine the treatment efficacy of CYH33 monotherapy in patients with recurrent or persistent ovarian, fallopian tube or primary peritoneal clear cell carcinoma harboring PIK3CA hotspot mutation, who received prior systemic anti-tumor treatment.

Detailed Description: The purpose of this study is to determine whether treatment with single agent CYH33 significantly improves ORR compared to historical efficacy data in patients with recurrent/persistent ovarian clear cell carcinoma (OCCC) harboring PIK3CA hotspot mutations who received prior systemic anti-tumor treatment.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, , China

Chinese PLA General Hospital, Beijing, , China

The First Affiliated Hospital of Chongqing Medical University, Chongqing, , China

The Southwest Hospital of AMU, Chongqing, , China

Sun Yat-sen University Cancer Center, Guangdong, , China

The First Affiliated Hospital, Sun Yat-sen University, Guangdong, , China

The First Affiliated Hospital of Hainan Medical College, Haikou, , China

The Third People's Hospital of Hainan Province, Hainan, , China

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, , China

Zhejiang Cancer Hospital, Hangzhou, , China

Harbin Medical University Cancer Hospital, Harbin, , China

Hubei Cancer Hospital, Hubei, , China

Hunan Cancer Hospital, Hunan, , China

Qilu Hospital of Shandong University, Jinan, , China

Jiangsu Province Hospital, Nanjing, , China

The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, , China

Qingdao Central Hospital, Qingdao, , China

Obstetrics & Gynecology Hospital of Fudan University, Shanghai, , China

Shanghai First Maternity and Infant Hospital, Shanghai, , China

Xiaohua wu, Shanghai, , China

West China Second University Hospital, Sichuan University, Sichuan, , China

Tianjin Medical University General Hospital, Tianjin, , China

Zhongnan Hospital of Wuhan University, Wuhan, , China

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, , China

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, , China

Kurume University Hospital, Kurume, Fukuoka, Japan

Osaka University Hospital, Suita, Osaka, Japan

National Cancer Center Hospital, Chuo Ku, Tokyo, Japan

Jikei University Hospital, Minato-Ku, Tokyo, Japan

Keio University Hospital, Shinjuku-Ku, Tokyo, Japan

Shikoku Cancer Center, Matsuyama, , Japan

Nagoya University Hospital, Nagoya, , Japan

Niigata University Medical & Dental Hospital, Niigata, , Japan

Okayama University Hospital, Okayama, , Japan

Hokkaido University Hospital, Sapporo, , Japan

Tohoku University Hospital, Sendai, , Japan

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: